日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Therapeutic effect of intracolonically administered nuclear factor kappa B (p65) antisense oligonucleotide on mouse dextran sulphate sodium (DSS)-induced colitis.

结肠内注射核因子κB(p65)反义寡核苷酸对小鼠葡聚糖硫酸钠(DSS)诱导的结肠炎的治疗效果

Murano M, Maemura K, Hirata I, Toshina K, Nishikawa T, Hamamoto N, Sasaki S, Saitoh O, Katsu K

Isosmotic modulation of Ca2+-regulated exocytosis in guinea-pig antral mucous cells: role of cell volume

豚鼠胃窦黏液细胞中钙离子调节胞吐作用的等渗调节:细胞体积的作用

Fujiwara, S; Shimamoto, C; Katsu, K i; Imai, Y; Nakahari, T

Inhibition of dextran sulphate sodium (DSS)-induced colitis in mice by intracolonically administered antibodies against adhesion molecules (endothelial leucocyte adhesion molecule-1 (ELAM-1) or intercellular adhesion molecule-1 (ICAM-1))

通过结肠内注射抗粘附分子(内皮白细胞粘附分子-1 (ELAM-1) 或细胞间粘附分子-1 (ICAM-1))的抗体,抑制葡聚糖硫酸钠 (DSS) 诱导的小鼠结肠炎。

Hamamoto, N; Maemura, K; Hirata, I; Murano, M; Sasaki, S; Katsu, K

In vitro and in vivo antifungal activities of ER-30346, a novel oral triazole with a broad antifungal spectrum

ER-30346是一种新型口服三唑类抗真菌药物,具有广谱抗真菌活性,本研究对其体外和体内抗真菌活性进行了研究。

Hata, K; Kimura, J; Miki, H; Toyosawa, T; Nakamura, T; Katsu, K

Efficacy of ER-30346, a novel oral triazole antifungal agent, in experimental models of aspergillosis, candidiasis, and cryptococcosis

新型口服三唑类抗真菌药物ER-30346在曲霉病、念珠菌病和隐球菌病实验模型中的疗效

Hata, K; Kimura, J; Miki, H; Toyosawa, T; Moriyama, M; Katsu, K